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Brilliant cresyl blue staining for screening 
hemoglobin H disease: Reticulocyte smear
Hemoglobin H hastalığında görüntüleme için brilliant cresyl blue boyaması: 
Retikülosit yayması
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A three-year-old boy was referred to our hospital with the 
complaint of anemia resistant to iron treatment. Laboratory 
examination revealed hemoglobin (Hb): 8.7 g/dl, hematocrit 
(Hct): 30%, red blood cell (RBC): 5.5x109/L, mean corpuscular 
volume (MCV): 54 fL, red cell distribution width (RDW): 21.6%, 
and platelet: 448x109/L. Peripheral blood smear examination 
revealed hypochromia, microcytosis, poikilocytosis and anisocy-
tosis. Reticulocyte count was 1%. The personal history was 
unremarkable and there was no consanguinity between parents. 
He had received no transfusions. Physical examination was 
unremarkable except for mild pallor and mild splenomegaly. 
Serum iron concentration and serum total iron binding capacity 
were 77 μmol/L and 362 μmol/L, respectively, and the transferrin 
saturation was 21.2%. Hemoglobin electrophoresis revealed 
HbA2: 1.5%, HbF: 1.9%, and HbH: 3.6%. We observed numer-
ous RBCs containing hemoglobin H (HbH) inclusions in the 
peripheral blood smear stained with brilliant cresyl blue (Figure1). 
Beta Globin Strip Assay (Vienna Lab; Vienna, Austria) was based 
on reverse hybridization. The mutational analyses using alpha 
Globin Strip Assay (Vienna Lab; Vienna, Austria) of the family 
revealed that the patient had - - MED II(-26.5)/-α3.7 deletions; the 
mother and father were found to have - - MED II(-26.5) and -α3.7 
deletions, respectively.
Although HbH is a common disease, it is rarely reported 
because of low suspicion [1,2]. In patients with hypochromic 
microcytic anemia without β-thalassemia trait and iron defi-
ciency, a simple reticulocyte stain can serve as a useful early 
rapid screening tool for detecting inclusions in patients with 
HbH disease.
This staining can be used as a screening procedure where 
the molecular diagnosis of HbH disease is not possible.
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Figure 1. Erythrocytes containing HbH inclusions in brilliant cresyl 
blue-stained smear